About us

Smart Science & Technology LLC

Smart Science & Technology (www.smartscitech.com) is a Houston publisher serving international science and technology communities with open access peer-reviewed journals covering frontier disciplines. All of the Journals published by Smart Science & Technology maintain the highest standards, with internationally-recognized editors and reviewers serving those journals. 

In addition, our excellent IT team developed a state-of-the-art anti-plagiarism software and system (Brand name: iPlagiarism; Website: www.iplagiarism.net) to serve global researchers, publishers, journals, and organizations. We are so proud and excited to announce that copyrights have been granted to iPlagiarism by United States Patent and Trademark Office (USPTO) and COPYRIGHT PROTECTION CENTER OF CHINA (CPCC) in 2016. 

Names and addresses of the owners of the publishing company.

Smart Science & Technology LLC was registered at 47 Litchfield Ln, Houston, Texas, United States. 

The owner: Dr. Xinjie Tan.

File Number (The State of Texas): 801845704.

EIN: 46-3614284.

Location of corporate office.

7001 Corporate Drive #315, Houston, TX 77036 United States.

Principal Contact

Phone: 800-339-8538

Fax: 800-339-8538

Support Contact

Phone: 800-339-8538

Email: admin@smartscitech.com

Members of the management team and where they are based.

Xinjie TAN, M.D., Ph.D.. Manager, Houston, USA.

David WU, M.D., Ph.D.. Scientific Editor, Houston, USA.

Jeffery DAI, M.D., M.S.. Language Editor, Houston, USA.

Lucy LYOU, M.S.. Financial Manager, Houston, USA.

Mike HUNAG, Ph.D.. Medical Statistics Director, Houston, USA.

Henry HUANG, M.S.. IT Manager, Houston, USA.

Stanley WANG, Ph.D.. PDF/XML/HTML and Art Editor, Houston, USA. 

Publishing credentials, and Names and affiliations of individuals responsible for the scientific quality of publications.

Manager: Xinjie TAN, M.D., Ph.D.

Experience:

Research Assistant Professor, Center for Nuclear Receptors and Cell Signaling, University of Houston.

Professor and Neurologist, the Second Hospital, Chongqing Medical University.

Editor-in-Chief: Receptors & Clinical Investigation (ISSN: 2330-0566), Stem Cell and Translational Investigation (ISSN: 2377-2557)

Journal Reviewer: GENE, International Journal of Biological Sciences,Journal of Cellular Physiology, Cellular Physiology and Biochemistry, FASEB Journal,Clinica Chimica Acta,Journal of Cardiovascular Pharmacology

Grant Reviewer: National Natural Science Foundation of China,Changjiang Scholar (Ministry of Education, China)

Grant P.I.: ERβ-selected agonist alleviates inflammation in multiple sclerosis model via regulation of MHC Ⅱ in microglia (NSFC, No. 81571167), Migration of neuronal precursors regulated by HIF-1α and SDF-1α/CXCR4 (NSFC, No.30800319)

Representative Publications:

Lifen Chen, Xi Liu, Tao Xu, Shu Ou, Shiyong Liu, Jinxian Yuan, Hao Huang, Lu Qin, Hui Yang, Xinjie Tan, Yangmei Chen. (2016) New Differentially Expressed Genes and Differential DNA Methylation underlying Refractory Epilepsy. Submitted.

Hao Zhou, Ye Liu, Xin-Jie Tan, Yu-Chuan Wang, Kai-Yu Liu, Yu-Xia Cui. (2015) Inhibitory effect of arsenic trioxide on neuronal migration in vitro and its potential molecular mechanism. Environ ToxicolPharmacol, 40:671-677.

Wu WF, Tan XJ, Dai YB, Krishnan V, Warner M, Gustafsson JÅ. (2013)Targeting estrogen receptor β in microglia and T cells to treat experimental autoimmune encephalomyelitis. Proc Natl AcadSci USA, 110:3543-3548.

Dai YB, Tan XJ, Wu WF, Warner M, Gustafsson JÅ. (2012) Liver X receptor β protects dopaminergic neurons in a mouse model of Parkinson disease. Proc Natl AcadSci USA, 109:13112-13117.

Tan XJ, Dai YB, Wu WF, Warner M, Gustafsson JÅ. (2012) Anxiety in liver X receptor β knockout female mice with loss of glutamic acid decarboxylase in ventromedial prefrontal cortex. Proc Natl AcadSci USA, 109:7493-7498.

Tan XJ, Dai YB, Wu WF, Kim HJ, Barros RP, Richardson TI, Yaden BC, Warner M, McKinzie DL, Krishnan V, Gustafsson JA. (2012) Reduction of dendritic spines and elevation of GABAergic signaling in the brains of mice treated with an estrogen receptor β ligand. Proc. Natl. Acad. Sci. USA, 109:1708-1712.

Tan Xinjie, et al. (2012) Analyses of regulation mechanisms and roles of the HIF-1α and SDF-1α/CXCR4 on astrocytes during hypoxia stress. Journal of Apoplexy and Nervous Diseases, 8:676-679.

Tan XJ, Fan XT, Kim HJ, Butler R, Webb P, Warner M, Gustafsson JA. (2010) Liver X receptor β and thyroid hormone receptor α in brain cortical layering. Proc. Natl. Acad. Sci. USA, 107, 12305-12310.

Scientific Editor: David WU, M.D., Ph.D.

Experience:

Scientist, Center for Nuclear Receptors and Cell Signaling, University of Houston.

Neurologist, First Hospital affiliated to Chongqing Medical University.

Editor-in-Chief: Therapeutic Targets for Neurological Diseases (ISSN: 2376-0478)

Journal Editor: Journal of Parkinson's Disease and Alzheimer's Disease

Journal Reviewer: Neuroendocrinology, Frontiers in Cellular Neuroscience, The Clinical Respiratory Jorunal, Neural Regeneration Research, Neuroscience & Medicine

Representative Publications:

Yu Z, Tang L, Chen L, Li J, Wu W, Hu C. (2015) Role for HIF-1α and Downstream Pathways in Regulating Neuronal Injury after Intracerebral Hemorrhage in Diabetes. Cell PhysiolBiochem, 37:67-76.

Yu Z, Tang L, Chen L, Li J, Wu W, Hu C. (2015) Capillarisin Suppresses Lipopolysaccharide-Induced Inflammatory Mediators in BV2 Microglial Cells by Suppressing TLR4-Mediated NF-κB and MAPKs Signaling Pathway. Neurochem Res, 40:1095-101.

Candelaria NR, Addanki S, Zheng J, Nguyen-Vu T, Karaboga H, Dey P, Gabbi C, Vedin LL, Liu K, Wu W, Jonsson PK, Lin JZ, Su F, Bollu LR, Hodges SE, McElhany AL, Issazadeh MA, Fisher WE, Ittmann MM, Steffensen KR, Gustafsson JÅ, Lin CY. (2014) Antiproliferative effects and mechanisms of liver X receptor ligands in pancreatic ductal adenocarcinoma cells. PLoS One,9:e106289.

Dai YB, Wu WF, Huang B, Miao YF, Nadarshina S, Warner M, Gustafsson JÅ. (2015) Liver X receptors regulate cerebrospinal fluid production. Mol Psychiatry, doi:10.1038/mp.2015.133.

Zhang X, Huang S, Gao M, Liu J, Jia X, Han Q, Zheng S, Miao Y, Li S, Weng H, Xia X, Du S, Wu W, Gustafsson JÅ, Guan Y. (2014) Farnesoid X receptor (FXR) gene deficiency impairs urine concentration in mice. Proc Natl AcadSci U S A, 111:2277-2282.

Wu WF, Tan XJ*, Dai YB, Krishnan V, Warner M, Gustafsson JÅ. (2013)Targeting estrogen receptor β in microglia and T cells to treat experimental autoimmune encephalomyelitis. Proc Natl AcadSci USA, 110:3543-3548.

Yu Z, Tang L, Chen L, Li J, Wu W, Hu C.  (2013) Erythropoietin reduces brain injury after intracerebral hemorrhagic stroke in rats. Mol Med Rep, 8:1315-1322. 

Dai YB, Tan XJ, Wu WF, Warner M, Gustafsson JÅ. (2012) Liver X receptor β protects dopaminergic neurons in a mouse model of Parkinson disease. Proc Natl AcadSci USA, 109:13112-13117.

Tan XJ, Dai YB, Wu WF, Warner M, Gustafsson JÅ. (2012) Anxiety in liver X receptor β knockout female mice with loss of glutamic acid decarboxylase in ventromedial prefrontal cortex. Proc Natl AcadSci USA, 109:7493-7498.

Tan XJ, Dai YB, Wu WF, Kim HJ, Barros RP, Richardson TI, Yaden BC, Warner M, McKinzie DL, Krishnan V, Gustafsson JA. (2012) Reduction of dendritic spines and elevation of GABAergic signaling in the brains of mice treated with an estrogen receptor β ligand. Proc. Natl. Acad. Sci. USA, 109:1708-1712.

Language Editor: Jeffery DAI, M.D., M.S.

Experience:

Assistant Professor, Department of Biology and Biochemistry, University of Houston.

Attending Surgeon, Department of Otolaryngology, Guizhou Provincial Hospital.

Journal Editor: International Journal of Otolaryngology and Head & Neck Surgery, Receptors & Clinical Investigation

Reviewer: Frontiers in Cellular Neuroscience,Journal of Neuroimmune Pharmacology,British Journal of Cancer,Clinical Respiratory Journal,International Journal of Otolaryngology and Head & Neck Surgery, Liver International, Frontiers in Clinical Medicine

Member: European Rhinologic Society,European Academy of Allergy and Clinical Immunology

Representative Publications:

Dai YB, Miao YF, Wu WF, Li Y, D'Errico F, Su W, Burns AR, Huang B, Maneix L, Warner M, Gustafsson JÅ. Ablation of Liver X receptors α and β leads to spontaneous peripheral squamous cell lung cancer in mice. Proc Natl Acad Sci USA. 2016 Jun 22. pii: 201607590. [Epub ahead of print] (IF: 9.423)

Dai YB, Wu WF, Huang B, Miao YF, Nadarshina S, Warner M, Gustafsson JÅ. Liver X Receptors regulate cerebrospinal fluid production. Mol Psychiatry. 2016; 21(6):844-56. (IF: 13.314)

Song Z, Zhang X, Zhang L, Xu F, Tao X, Zhang H, Lin X, Kang L, Xiang Y, Lai X, Zhang Q, Huang K, Dai Y, Yin Y, Cao J. Progranulin Plays a Central Role in Host Defense During Sepsis by Promoting Macrophage Recruitment. Am J Respir Crit Care Med. 2016 May 5. [Epub ahead of print] (IF: 13.118)

Ye H, Gong Z, Yang W, Dai Y#. Primary non-Hodgkin lymphoma of the sphenoid sinus with visual disturbance: A report of two cases. Oncol Lett. 2016; 11(6):4252-4254. (IF: 1.482) #corresponding author

Peng Y, Zhang L, Hu D, Dai Y, Wang S, Liao H, Xiong Y. Reduction of internal carotid artery intima-media thickness in patients with moderate-to-severe obstructive sleep apnea syndrome after nasal surgery and uvulopalatopharyngoplasty. Acta Otolaryngol. 2016; 136(5):514-21. (IF: 1.127)

Li Y, Dai YB, Sun JY, Xiang Y, Yang J, Dai SY, Zhang X. Neuroglobin Attenuates Beta Amyloid-Induced Apoptosis Through Inhibiting Caspases Activity by Activating PI3K/Akt Signaling Pathway. J Mol Neurosci. 2016; 58(1):28-38. (IF: 2.352)

Ma ZX, Tan X, Shen Y, Ke X, Yang YC, He XB, Wang ZH, Dai YB, Hong SL, Hu GH. MicroRNA expression profile of mature dendritic cell in chronic rhinosinusitis. Inflamm Res. 2015; 64(11):885-93. (IF: 2.557)

Miao Y, Wu W, Dai Y, Maneix L, Huang B, Warner M, Gustafsson JÅ. Liver X receptor β controls thyroid hormone feedback in the brain and regulates browning of subcutaneous white adipose tissue. Proc Natl Acad Sci USA. 2015; 112(45):14006-11. (IF: 9.423)

Tang ZY, Zhao JN, Zhong WJ, Luo YD, Wu W, Chen WJ, Dai YB. The Value of Proton Magnetic Resonance Spectroscopy in High-Intensity Focused Ultrasound Treatment of Experimental Liver Cancer. Transl Oncol. 2015; 8(3):163-8. (IF: 3.077)

Ju Cao, Dongsheng Wang, Fang Xu, Yi Gong, Hong Wang, Zixin Song, Dageng Li, Hua Zhang, Dairong Li, Liping Zhang, Yun Xia, Huajian Xu,  Xaiofei Lai, Shihui Lin, Xuemei Zhang, Guosheng Ren, Yubing Dai, Yibing Yin. Activation of IL-27 signaling promotes development of postinfluenza pneumococcal pneumonia. EMBO Molecular Medicine. EMBO Mol Med. 2014; 6(1):120-40. (IF: 9.547)

Wu WF*, Tan XJ*, Dai YB*, Venkatesh Krishnan, Warner M, Gustafsson JÅ. Targeting estrogen receptor β in microglia and T cells to treat experimental autoimmune encephalomyelitis. Proc Natl Acad Sci USA. 2013; 110(9): 3543-8. (IF: 9.423) *Co-first author.

Dai YB, Tan XJ, Wu WF, Warner M, Gustafsson JÅ. Liver X receptor β protects dopaminergic neurons in a mouse model of Parkinson disease. Proc Natl Acad Sci USA. 2012; 109(32):13112-7. (IF: 9.423)

Tan XJ*, Dai YB*, Wu WF, Warner M, Gustafsson JÅ. Anxiety in Liver X Receptor β knockout female mice with normal dorsal raphe but with loss of Glutamic Acid Decarboxylase in ventromedial prefrontal cortex. Proc Natl Acad Sci USA. 2012; 109(19):7493-8. (IF: 9.423) *Co-first author.

Tan XJ, Dai YB, Wu WF, Kim HJ, Barros RP, Richardson TI, Yaden BC, Warner M, McKinzie DL, Krishnan V, Gustafsson JÅ. Reduction of dendritic spines and elevation of GABAergic signaling in the brains of mice treated with an estrogen receptor β ligand. Proc Natl Acad Sci USA. 2012; 109(5):1708-12. (IF: 9.423)

Financial Manager: Lucy LYOU, M.S.

Education: University of Houston-Clear Lake.

Medical Statistics Director: Mike HUANG, Ph.D.

Education: Tsinghua University

IT Manager: Henry HUANG, M.S.

Education: University of Houston and Guizhou University.

PDF/XML/HTML and Art Editor: Stanley WANG, Ph.D.

Education: the State University of New Jersey.

Editorial Policies

The structure of our editorial office of the Journal mirrors that of many other academic journals including managing editor, scientific editor, IT specialist, art editor, and language editor. The tasks performed in the editorial office include, but are not limited to:

Management of the peer review process – ensure manuscripts progress smoothly through peer review; reviewers have all the information they need; authors receive a review that improves the quality of their manuscript.

Issue compilation – assembling issues on time.

Editing – copyediting and proof-reading manuscripts; reformatting manuscripts to conform to journal house style.

Queries – handling problems; assisting with submissions; answering general questions about the journal such as requests for information on time from submission to acceptance.

The roles and responsibilities of editorial offices are evolving rapidly, in response to the trend of online-based workflows. Editorial office staff constantly analyzes data such as citation levels, usage, and author submission behavior to determine content that would enhance readership by a variety of different criteria.

Selecting Editors

Editors play a key role on our journals: they put their reputation and name to the journal, they help publishers steer the strategic direction of the journal and they oversee the journal's peer-review process. Usually, editors are selected by the journal’s editor-in-chief or suggested by existing editors, with input from the publisher. However, editors from internationally key research institutes may be considered and invited by the publisher in priority. Former Guest Editors of special issues, and authors of key reviews, and top reviewers may be suitable. Editors generally undergo a complete revision every four or five years, with editors joining, stepping down or continuing for another term. Changes also occur in the interim, for example if an editor resigns. A journal’s editorial board can affect its quality, so editors should also consider the following:

·       The location of editors should represent the reach of the journal

·       Editors’ expertise should represent the journal's scope

Editorial and Peer Review processes

Each journal has enlisted the members of an Editorial Board with broad expertise in many relevant research areas, but will also solicit the help of other specialists as required. Each member of the Board is involved with strong research programs into many aspects of normal and/or pathological condition, and will make every effort to fulfill the mandate of the journal. The Board promise to conduct and facilitate unbiased and critical reviews of manuscripts and will strive to expedite the communication of work that is original, scientifically sound and thought provoking. Generally peer review is completed within 4-6 weeks and the editor’s decision within 2-7 days of this.  

 

Peer-review Policy

General information

The following types of manuscripts are single-blind peer-reviewed: Research articles, Brief reports, Hypotheses, Reviews, Case reports. Editorials, Research highlights, Commentaries, and all forms of published correction may also be peer-reviewed at the discretion of the editors.

Online review

Editors will email selected Reviewers the title and abstract of the submission, as well as an invitation to log into the journal web site to complete the review. Reviewers enter the journal web site to agree to do the review, to download submissions, submit their comments, and select a recommendation.

Selecting peer-reviewers

Reviewer selection is critical to the publication process, and we base our choice on many factors, including expertise, reputation, specific recommendations and our own previous experience of a reviewer's characteristics.

Review guidelines

The reviewer should provide an honest, critical assessment of the research. The reviewer’s job is to analyze the strengths and weaknesses of the research, provide suggestions for improvement, and clearly state what must be done to raise the level of enthusiasm for the work. The reviewer should not manipulate the process to force the authors to address issues interesting or important to the reviewer but peripheral to the objective(s) of the study.

The reviewer should also maintain confidentiality about the existence and substance of the manuscript. It is not appropriate to share the manuscript or to discuss it in detail with others or even to reveal the existence of the submission before publication. There are some exceptions, if approved by the editor. One exception is that the reviewer may want a junior colleague to have the experience of reviewing and therefore may ask him/her to collaborate on a review. However, if this is done, your collaborator on the review should also agree to maintain confidentiality, and the editor should be informed of the participation of this additional person.

The reviewer must not participate in plagiarism. It is obviously a very serious transgression to take data or novel concepts from a paper to advance your own work before the manuscript is published.

The reviewer should always avoid, or disclose, any conflicts of interest. For example, the reviewer should decline to review a manuscript on a subject in which he/she is involved in a contentious dispute and does not feel that a fair review can be provided. The reviewer should also avoid biases that influence the scientific basis for a review. Another example is if the reviewer has a close personal or professional relationship with one or more of the authors such that his/her objectivity would be compromised. Scientific merit should be the basis for all reviews.

The reviewer should accept manuscripts for review only in his/her areas of expertise. Although editors try very hard to match manuscripts with the most expert reviewers, sometimes mistakes are made. It is unfair to the authors and to the overall review process if the referee does not have the expertise to review the manuscript adequately. The exception to this general rule is when an editor specifically asks for your view as a "nonexpert" or seeks your opinion on a special aspect of the manuscript (e.g., statistics).

The reviewer should agree to review only those manuscripts that can be completed on time. Sometimes, unforeseen circumstances arise that preclude a reviewer from meeting a deadline, but in these instances the reviewer should immediately contact the editor.

The reviewer also has the unpleasant responsibility of reporting suspected duplicate publication, fraud, plagiarism, or ethical concerns about the use of animals or humans in the research being reported.

Peer Review processes

If you want to learn more about our peer review process, please check: http://www.journals.smartscitech.com/about_us.php or Editorial Policies of this journal.

Open Access Policy

All of the journals published by us provide immediate open access to its content on the principle that making research freely available to the public supports a greater global exchange of knowledge.

Authors of articles published in these journals retain the copyright of their articles. Author can archive pre-print, post-print, and publisher's versions.

Copyright

Articles published in these journals are licensed under a Creative Commons Attribution 4.0 International License which allows users including authors of articles to copy and redistribute the material in any medium or format, in addition to remix, transform, and build upon the material for any purpose, even commercially, as long as the author and original source are properly cited or credited.

Statement concerning Conflict of Interest

Each journal published by Smart Science & Technology LLC requires all authors and reviewers to declare any conflicts of interest that may be inherent in their submissions.

Conflict of interest for a given manuscript exists when a participant in the peer review and publication process – author, reviewer, or editor – has ties to activities that could inappropriately influence his or her judgment, whether or not judgment is in fact affected.

Financial relationships with industry, for example, through employment, consultancies, stock ownership, honoraria, expert testimony, either directly or through immediate family, are usually considered to be the most important conflicts of interest.

However, conflicts can occur for other reasons, such as personal relationships, academic competition, and intellectual passion.

Public trust in the peer review process and the credibility of published articles depend in part on how well conflict of interest is handled during writing, peer review, and editorial decision making. Bias can often be identified and eliminated by careful attention to the scientific methods and conclusions of the work.

Financial relationships and their effects are less easily detected than other conflicts of interest. Participants in peer review and publication should disclose their conflicting interests, and the information should be made available so that others can judge their effects for themselves.

Authors: When they submit a manuscript, whether an article or a letter, authors are responsible for recognizing and disclosing financial and other conflicts of interest that might bias their work. They should acknowledge in the manuscript all financial support for the work and other financial or personal connections to the work.

Reviewers: External peer reviewers should disclose to editors any conflicts of interest that could bias their opinions of the manuscript, and they should disqualify themselves from reviewing specific manuscripts if they believe it appropriate. The editors must be made aware of reviewers’ conflicts of interest to interpret the reviews and judge for themselves whether the reviewer should be disqualified. Reviewers should not use knowledge of the work, before its publication, to further their own interests.

For example, the statement on the journal of Receptors & Clinical Investigation can be found at http://www.smartscitech.com/index.php/rci/about/editorialPolicies#custom-5.

Statement concerning Human and Animal Rights

When reporting experiments on human subjects, authors should indicate whether the procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1975, as revised in 2000 (5). If doubt exists whether the research was conducted in accordance with the Helsinki Declaration, the authors must explain the rationale for their approach and demonstrate that the institutional review body explicitly approved the doubtful aspects of the study. When reporting experiments on animals, authors should indicate whether the institutional and national guide for the care and use of laboratory animals was followed. [International Committee of Medical Journal Editors ("Uniform Requirements for Manuscripts Submitted to Biomedical Journals") February 2006].

For example, the statement on the journal of Receptors & Clinical Investigation can be found at http://www.smartscitech.com/index.php/rci/about/editorialPolicies#custom-7.

Statement concerning Informed Consent for publications

Patients have a right to privacy that should not be violated without informed consent. Identifying information, including names, initials, or hospital numbers, should not be published in written descriptions, photographs, or pedigrees unless the information is essential for scientific purposes and the patient (or parent or guardian) gives written informed consent for publication. Informed consent for this purpose requires that an identifiable patient be shown the manuscript to be published. Authors should disclose to these patients whether any potential identifiable material might be available via the Internet as well as in print after publication. Patient consent should be written and archived either with the journal, the authors, or both, as dictated by local regulations or laws. Nonessential identifying details should be omitted. Informed consent should be obtained if there is any doubt that anonymity can be maintained. For example, masking the eye region in photographs of patients is inadequate protection of anonymity. If identifying characteristics are altered to protect anonymity, such as in genetic pedigrees, authors should provide assurance, and editors should so note, that such alterations do not distort scientific meaning. When informed consent has been obtained, it should be indicated in the published article.

For example, the statement on the journal of Receptors & Clinical Investigation can be found at http://www.smartscitech.com/index.php/rci/about/editorialPolicies#custom-6.

Advertising polices.

No advertisements are accepted.

Scientific quality of our publications.

The reviewers, editorial board members, Editor-in-Chief, and Editorial advisory board of each journal are responsible for the quality of the publications in addition to using of anti-plagiarism software from iPlagiarism and crosscheck. More information can be found at Journal Policies and Author Guidelines of each journal.

For example, Journal Policies can be found at http://www.smartscitech.com/index.php/rci/about and Author Guidelines can be found at http://www.smartscitech.com/index.php/rci/about/submissions#authorGuidelines.

Archiving

Digital Archiving: The journal utilizes several digital archives to guarantee long-term digital preservation and restoration such as the PKP LOCKSS developed by Public Knowledge Project (PKP). The journal also makes article metadata available in compliance with Open Archives Initiative Protocol for Metadata Harvesting (OAI-PMH) to enable automated harvesting of articles by as many international archives as possible, such as the PKP Open Archives Harvester. 

PubMed Central (PMC): NIH-funded papers are submitted to PubMed Central (PMC) for permanent archive in compliance with the NIH Public Access Policy. 

PubMed Central Canada (PMC Canada): CIHR-funded papers are submitted to PMC Canada for permanent archive in compliance with the Tri-Agency Open Access Policy on Publications.

Author Self-Archiving: Authors of articles retain the copyright of their articles. Author can archive pre-print, post-print, and publisher's versions.

Commercial Archiving (Bluehost): Journals published by Smart Science & Technology utilizes the Bluehost to create distributed archiving systems to create permanent archives of the journals for purposes of preservation and restoration.

 

Smart Science & Technology LLC | 7001 Corporate Drive #315, Houston, TX 77036 | 800-339-8538